Successful Low-Dose Immune Tolerance Induction Regimen Using Multiple Plasma-Derived Factor VIII Concentrates

被引：0
|
作者：
Colella, M. [1 ]
Montalvao, S. [1 ]
Sambo, A. [1 ]
De Paula, E. [1 ]
Ozelo, M. [1 ]
机构：
[1] Univ Estadual Campinas, Hemophilia Unit Claudio LP Correa INCT Sangue Hem, Campinas, Brazil
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [1] Changing recombinant factor VIII to plasma-derived factor VIII during immune tolerance induction
    Dias, Maise Moreira
    Camelo, Ricardo Mesquita
    de Magalhaes, Laura Peixoto
    Jardim, Leticia Lemos
    de Oliveira, Andrea Goncalves
    de Albuquerque Ribeiro, Rosangela
    Franco, Vivian Karla Brognoli
    de Araujo Callado, Fabia Michelle Rodrigues
    Lorenzato, Claudia Santos
    Rezende, Suely Meireles
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (01) : 74 - 80
  • [2] Successful immune tolerance induction with low-dose coagulation factor VIII in a patient with hemophilia A from a developing country
    Ay, Yilmaz
    Ersin, Toret
    Yesim, Oymak
    Hilkay, Karapinar Tuba
    Dilek, Ince
    Gulcihan, Ozek
    Ahmet, Koc
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (06) : 729 - 731
  • [3] Switching to low dose of plasma-derived factor VIII/vWF concentrates with Confact®-F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan
    Nagao, A.
    Oka, T.
    Hanabusa, H.
    HAEMOPHILIA, 2015, 21 (05) : E425 - E427
  • [4] Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors
    Unuvar, A.
    Kavakli, K.
    Baytan, B.
    Kazanci, E.
    Sayli, T.
    Oren, H.
    Celkan, T.
    Gursel, T.
    HAEMOPHILIA, 2008, 14 (02) : 315 - 322
  • [5] Immune Tolerance Induction (ITI) with a Plasma-Derived Factor VIII for Patients with Hemophilia a and Inhibitors: A Retrospective Study
    Escobar, Miguel A.
    Shaffer, Linda
    Holguin, Mark
    McCavit, Timothy
    Rajan, Sandeep K.
    Amega, Novinyo
    BLOOD, 2019, 134
  • [6] Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2010, 8 (04) : 288 - 291
  • [7] Immune tolerance protocols using low-dose factor VIII: A review of the literature
    Sultan, Y
    VOX SANGUINIS, 1999, 77 : 55 - 56
  • [8] Viral safety of plasma-derived factor VIII and IX concentrates
    Ludlam, CA
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S19 - S23
  • [9] Case study immune-tolerance in haemophilia a using plasma-derived factor VIII concentrate
    Needham, J.
    Roy, A.
    Knight, S.
    Stebbings, Y.
    Rangarajan, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1133 - 1134
  • [10] Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates
    Lin, Y
    Yang, X
    Chevrier, MC
    Craven, S
    Barrowcliffe, TW
    Lemieux, R
    Ofosu, FA
    HAEMOPHILIA, 2004, 10 (05) : 459 - 469
12345